Target intelligence / Profile preview

Major allergen Dac g 6 (Dac g 6)

Target
Dac g 6
Molecular classification
Allergen, Grass pollen allergen, Group 6 grass allergen
01

Overview

Dac g 6 is a major protein allergen derived from the pollen of Dactylis glomerata, commonly known as Orchard grass or Cocksfoot grass (UniProt P43215). It belongs to the Group 6 grass pollen allergens, which are typically small, acidic proteins with a molecular weight of approximately 11-12 kDa (WHO/IUIS Allergen Nomenclature). In sensitized individuals, Dac g 6 binds to specific IgE antibodies on the surface of mast cells and basophils, triggering the release of inflammatory mediators that cause symptoms of allergic rhinitis, conjunctivitis, and asthma (PubMed: 7521631). While its exact biological function in the plant is not fully characterized, it is a critical target in the diagnosis and treatment of seasonal allergies. Therapeutic intervention involves allergen-specific immunotherapy (AIT), where controlled exposure to the allergen aims to desensitize the immune system and induce long-term tolerance (PubMed: 29055014). Monitoring of Dac g 6-specific IgE and IgG4 levels is often used to assess patient sensitivity and the efficacy of treatment.

Other names
Dactylis glomerata allergen 6Orchard grass allergen 6Cocksfoot grass allergen 6
02

Mechanism of action

Allergen-specific immunotherapy (AIT) works by inducing immune tolerance through the administration of increasing doses of the allergen, leading to a shift from a Th2 to a Th1 immune response, the production of regulatory T cells, and the induction of allergen-specific IgG4 antibodies that block IgE-mediated mast cell activation (PubMed: 29055014).

03

Biological functions

Immune responseIgE bindingMast cell degranulation
04

Disease associations

Allergic rhinitisAllergic conjunctivitisAsthmaPollinosis
05

Safety considerations

AnaphylaxisSystemic allergic reactionsLocal injection site reactionsBronchospasm
06

Interacting drugs

Orchard grass pollen extract

2 more in the full profile.

07

Biomarkers

Specific IgE (sIgE) to Dac g 6Specific IgG4 (sIgG4) to Dac g 6Skin prick test (SPT) reactivity

Beyond the preview

Go deeper on Major allergen Dac g 6 (Dac g 6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major allergen Dac g 6 (Dac g 6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call